BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 2208692
Publisher
Wiley
Online
2022-11-19
DOI
10.1002/adma.202208692
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
- (2022) Emma Verheye et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
- (2021) Leona Yamamoto et al. Frontiers in Oncology
- Bone marrow‐derived mesenchymal stem cells inhibit CD8 + T cell immune responses via PD‐1/PD‐L1 pathway in multiple myeloma
- (2021) Z. Liu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells
- (2021) Eric Freund et al. ONCOLOGY REPORTS
- Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
- (2021) Liu Zhaoyun et al. Frontiers in Immunology
- Immunotherapy of multiple myeloma
- (2020) Simone A. Minnie et al. JOURNAL OF CLINICAL INVESTIGATION
- Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death
- (2020) Jun Li et al. Science China-Chemistry
- Immune-based therapies in the management of multiple myeloma
- (2020) Saurabh Zanwar et al. Blood Cancer Journal
- Targeting immunogenic cell death in cancer
- (2020) Asma Ahmed et al. Molecular Oncology
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Semiconducting Perylene Diimide Nanostructure: Multifunctional Phototheranostic Nanoplatform
- (2019) Zhen Yang et al. ACCOUNTS OF CHEMICAL RESEARCH
- Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
- (2019) Wenwen Yue et al. Nature Communications
- Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
- (2019) Nathan Suek et al. Frontiers in Immunology
- Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
- (2019) Siler H. Panowski et al. MOLECULAR CANCER THERAPEUTICS
- Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure
- (2019) Chao Chen et al. ADVANCED MATERIALS
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
- (2018) Carlyn Rose C. Tan et al. CLINICAL PHARMACOKINETICS
- Global Burden of Multiple Myeloma
- (2018) Andrew J. Cowan et al. JAMA Oncology
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
- (2018) Quanyin Hu et al. Nature Biomedical Engineering
- Is immunotherapy here to stay in multiple myeloma?
- (2017) Paula Rodríguez-Otero et al. HAEMATOLOGICA
- A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging
- (2017) Alexander L. Antaris et al. Nature Communications
- Is immunotherapy here to stay in multiple myeloma?
- (2017) Paula Rodríguez-Otero et al. HAEMATOLOGICA
- The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus
- (2017) Jacques C. Mbongue et al. Frontiers in Immunology
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions
- (2017) Ogbonna Collins Nwabuko et al. Cancer Management and Research
- CD57 in human natural killer cells and T-lymphocytes
- (2016) Hassen Kared et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
- (2016) Abhishek D. Garg et al. Science Translational Medicine
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Nanoparticles in Photodynamic Therapy
- (2015) Sasidharan Swarnalatha Lucky et al. CHEMICAL REVIEWS
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
- (2015) Henk M. Lokhorst et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma
- (2014) Jessica Rueff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma
- (2013) D Atanackovic et al. LEUKEMIA
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
- (2012) Philippe Moreau et al. CLINICAL PHARMACOKINETICS
- Enlightening the impact of immunogenic cell death in photodynamic cancer therapy
- (2012) Lorenzo Galluzzi et al. EMBO JOURNAL
- Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
- (2011) Abhishek D. Garg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
- (2010) A. P. Rapoport et al. BLOOD
- Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma
- (2010) Ross D. Brown et al. LEUKEMIA & LYMPHOMA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started